The Global Recombinant Proteins Market size is estimated to grow at a CAGR of around 7.4% during the forecast period, i.e., 2024-30.
Global Recombinant Proteins Market Driver:
The Growing Prevalence of Chronic Diseases Driving Market Growth – The increasing occurrence of conditions like cerebral apoplexy, multiple sclerosis, neutropenia, thrombocytopenia, etc., has been driving the need for recombinant protein drugs. Additionally, treatment methods such as cancer therapy, mammalian cell culture, recombinant protein western blot, recombinant DNA, animal cell culture, glycosylation, biotherapeutics, and bioengineering are witnessing heightened demand, contributing significantly to overall market growth worldwide. In addition, one of the major chronic diseases witnessing rapid growth is cancer. For instance,
- In 2022, according to the American Cancer Society’s 2022 statistics, approximately 1,918,030 new cancer cases were estimated in the United States alone for the year.
These increasing occurrences of illnesses among the inhabitants are resulting in the shift towards innovative health treatments. As a result, several non-government organizations are increasingly funding the pharma & bio-pharma companies to develop highly effective drugs. The continuous research & development of high-efficacy drugs would continue to elevate the requirement for recombinant proteins, uplifting the Global Recombinant Proteins Market in the forecast period.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/recombinant-proteins-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/recombinant-proteins-market.html
Global Recombinant Proteins Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2023
-Historical Period: 2019 to 2022
-Forecast Period: 2024 to 2030
- By Product
- Growth Factors and Cytokines- Market Size & Forecast 2019-2030F, USD Billion
- Epidermal Growth Factor (EGF)- Market Size & Forecast 2019-2030F, USD Billion
- Platelet-Derived Growth Factor (PDGF)- Market Size & Forecast 2019-2030F, USD Billion
- Fibroblast Growth Factor (FGF)- Market Size & Forecast 2019-2030F, USD Billion
- Interferons- Market Size & Forecast 2019-2030F, USD Billion
- Interleukins- Market Size & Forecast 2019-2030F, USD Billion
- Others (Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor-Beta (TGF-?), etc.)
- Antibodies- Market Size & Forecast 2019-2030F, USD Billion
- Immune Checkpoint Proteins- Market Size & Forecast 2019-2030F, USD Billion
- Structural Proteins- Market Size & Forecast 2019-2030F, USD Billion
- Enzymes- Market Size & Forecast 2019-2030F, USD Billion
- Kinases- Market Size & Forecast 2019-2030F, USD Billion
- Hydrolase- Market Size & Forecast 2019-2030F, USD Billion
- Others (Proteases, Lipases, etc.)- Market Size & Forecast 2019-2030F, USD Billion
- Recombinant Regulatory Proteins- Market Size & Forecast 2019-2030F, USD Billion
- Hormones- Market Size & Forecast 2019-2030F, USD Billion
- Others (Membrane Proteins, Adhesion Molecules & Receptors, etc.)- Market Size & Forecast 2019-2030F, USD Billion
- Growth Factors and Cytokines- Market Size & Forecast 2019-2030F, USD Billion
- By Host Cells
- Mammalian Cells- Market Size & Forecast 2019-2030F, USD Billion
- Insect Cells- Market Size & Forecast 2019-2030F, USD Billion
- Yeast & Fungi- Market Size & Forecast 2019-2030F, USD Billion
- Bacterial Cells- Market Size & Forecast 2019-2030F, USD Billion
- Others- Market Size & Forecast 2019-2030F, USD Billion
- By Application
- Therapeutics- Market Size & Forecast 2019-2030F, USD Billion
- Biologics- Market Size & Forecast 2019-2030F, USD Billion
- Vaccines- Market Size & Forecast 2019-2030F, USD Billion
- Cell & Gene Therapies- Market Size & Forecast 2019-2030F, USD Billion
- Others (Immunotherapy, Regenerative Medicine, etc.) – Market Size & Forecast 2019-2030F, USD Billion
- Research & Development- Market Size & Forecast 2019-2030F, USD Billion
- Diagnostics- Market Size & Forecast 2019-2030F, USD Billion
- Biotechnology- Market Size & Forecast 2019-2030F, USD Billion
- Others (Industrial, Cosmetics & Personal Care, etc.) – Market Size & Forecast 2019-2030F, USD Billion
- Therapeutics- Market Size & Forecast 2019-2030F, USD Billion
- By End Users
- Pharmaceutical & Biopharmaceutical Companies- Market Size & Forecast 2019-2030F, USD Billion
- Research Institutes and Academic Institutions – Market Size & Forecast 2019-2030F, USD Billion
- Diagnostic Laboratories- Market Size & Forecast 2019-2030F, USD Billion
- Others (Contract Research Organizations (CROs), Biotechnology Companies, etc.)- Market Size & Forecast 2019-2030F, USD Billion
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Novozymes A/S, GenScript Biotech Corporation, R&D Systems, Inc., ProSpec-Tany TechnoGene Ltd., Cell Signaling Technology, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., Miltenyi Biotec, Abnova Corporation, RayBiotech, Inc., OriGene Technologies, Inc., Others
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/recombinant-proteins-market.html
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
